Compare PTEN & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTEN | RXRX |
|---|---|---|
| Founded | 1978 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.4B |
| IPO Year | 1993 | 2021 |
| Metric | PTEN | RXRX |
|---|---|---|
| Price | $7.08 | $4.64 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 4 |
| Target Price | $7.25 | ★ $7.50 |
| AVG Volume (30 Days) | 10.4M | ★ 24.4M |
| Earning Date | 02-04-2026 | 02-27-2026 |
| Dividend Yield | ★ 4.50% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,837,946,000.00 | $43,689,000.00 |
| Revenue This Year | N/A | $6.74 |
| Revenue Next Year | N/A | $34.31 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.10 | $3.79 |
| 52 Week High | $9.58 | $12.36 |
| Indicator | PTEN | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 67.18 | 53.07 |
| Support Level | $7.00 | $4.61 |
| Resistance Level | $7.46 | $4.98 |
| Average True Range (ATR) | 0.30 | 0.23 |
| MACD | 0.07 | 0.05 |
| Stochastic Oscillator | 78.37 | 65.79 |
Patterson-UTI Energy Inc is one of the substantial land rig drilling contractors in the United States. Its 2023 merger with NexTier greatly expanded its pressure pumping operations, as well, and the firm now controls nearly 20% of the North American market for drilling and completions services. The company operates under three reportable business segments: (i) drilling services, (ii) completion services, and (iii) drilling products. It also provides directional drilling services and tool rental services in united states onshore oil and gas basins.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.